Philips selected for ARPA-H program to advance AI-enabled robotic stroke care

{
  "signal_id": "1b90cd82-b9ba-361e-d963-2a7cfbd8ad9e",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-08-26T13:03:00+00:00",
  "company": {
    "name": "Philips",
    "domain": "philips.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/08/26/3351416/0/en/philips-selected-for-arpa-h-program-to-advance-ai-enabled-robotic-stroke-care.html",
    "title": "Philips selected for ARPA-H program to advance AI-enabled robotic stroke care",
    "excerpt": "August 26, 2026 Cambridge, MA, USA and Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received an up to US$33.7 million award under the Advanced Research Projects Agency for Health ( ARPA-H , an agency within the U.S. Department of Health and Human Services (HHS)) Autonomous Interventions and Robotics ( AIR ) program, led by Dr. Ileana Hancu, to advance AI-enabled robotic procedure automation for stroke care. Working with Johns Hopkins University, Boston University, and Dr. J Mocco of Weill Cornell Medicine, Philips will develop technologies for remote-assisted and increasingly automated endovascular procedures, helping expand access to advanced stroke care. Access to timely stroke treatment remains one of healthcare's greatest challenges. In the United States, approximately 335,000 patients each year are eligible for thrombectomy [1], a minimally invasive procedure that, when performed early enough, can reverse the effects of a stroke and prevent long-term disability. Yet only around 12% of eligible patients receive the treatment [1], while more than half of Americans live over an hour from a hospital capable of performing it.[1] Globally, fewer than 3% of eligible patients with large-vessel occlusion receive mechanical thrombectomy, despite stroke remaining the world's second leading cause of...",
    "summary": "Royal Philips is partnering with Dr. J Mocco of Weill Cornell Medicine to develop technologies for remote-assisted and automated endovascular procedures for stroke care.",
    "location": "Cambridge, MA, USA",
    "planning": true,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/01750c10-9afe-444f-8ef2-dca91839afb8",
    "confidence": 0.9,
    "published_at": "2026-08-26T13:03:00Z",
    "location_data": [
      {
        "city": "Cambridge",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Working with Johns Hopkins University, Boston University, and Dr. J Mocco of Weill Cornell Medicine, Philips will develop technologies for remote-assisted and increasingly automated endovascular procedures, helping expand access to advanced stroke care.",
    "related_company_name": "Weill Cornell Medicine",
    "related_company_domain": "weill.cornell.edu"
  }
}

curl https://signals.autobound.ai/v1/signals/1b90cd82-b9ba-361e-d963-2a7cfbd8ad9e \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"philips.com","limit":20}'